Technical Overview

Infinium Global Screening Array (GSAv3.0)

CAP/CLIA validated high-throughput genotyping array with 654,027 fixed markers. Used for genome-wide genotyping applications with 24 samples per array.

Test Information:

Deliverables: Raw IDAT files and/or VCF files (in hg19 or hg38 genome build)
Platform: Illumina iScan
Sample Types: Saliva and Whole blood
Turnaround Time: 5-10 business days
Minimum Sample Size: Minimum batch size for sampe submission is 24, but preferred is 48.
Applications: Genetic disease research, pharmacogenomics, population studies

About the Service

This cutting-edge service utilizes a CAP/CLIA-validated genotyping array featuring 654,027 fixed markers, enabling comprehensive genetic analysis for a wide range of clinical and research applications.

Unmatched Performance and Throughput

Our high-throughput microarray platform processes 24 samples per array, ensuring rapid turnaround times while maintaining the highest standards of quality and reliability. This advanced technology allows for large-scale genomic studies, making it an ideal solution for both clinical diagnostics and population-level genetic research.

Key Applications

The Clinical Microarray Service supports various high-impact applications, including:

Genetic Disease Research: Identify associations between genetic variants and inherited disorders, aiding in disease understanding and early diagnosis.
Pharmacogenomics: Assess genetic variations that influence drug metabolism and response, enabling personalized treatment strategies.
Population Studies: Investigate genetic diversity, ancestry, and evolutionary trends across different populations for epidemiological and biomedical research.

Benefits of Eurofins Genomics' Clinical Microarray Service

CAP/CLIA Validation: Ensures compliance with the highest clinical standards for accuracy and reproducibility.
Extensive Marker Coverage: A robust array of 654,027 fixed markers provides comprehensive genomic insights.
Scalability: High-throughput capacity supports large-scale projects with efficiency and precision.
Expert Support: Our team of genomic specialists provides guidance from study design to data interpretation.

Eurofins Genomics remains committed to advancing genomic solutions for clinical and research communities. With the launch of our Clinical Microarray Service, we empower scientists, clinicians, and researchers with the tools they need for groundbreaking discoveries in genetics and precision medicine.

For more information or to inquire about our Clinical Microarray Service, contact our team today!

Applications

Population Studies

Genetic Disease

Clinical

Sequencing

Pharmacogenomics

View All Applications

Get Started

Contact us today to learn more about our Clinical Whole Genome Sequencing services and how they can support your research and clinical applications.

Eurofins Clinical Enterprise and Eurofins Genomics

Eurofins Clinical Enterprise (CE) is the clinical arm of Eurofins Genomics. CE processes all clinical and non-clinical NGS samples for Eurofins Genomics in the United States. Samples, quotes, and results are managed through the CE group.

Clinical Microarrays